Mosmi N. Surati

Hospital Medicine
1700 W Van Buren St Ste 500
Chicago, IL 60612

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Buried Deep.

Buried Deep.

Journal: Journal of hospital medicine
Published: August 07, 2020

Expression and mutational analysis of c-CBL and its relationship to the MET receptor in head and neck squamous cell carcinoma.

Expression and mutational analysis of c-CBL and its relationship to the MET receptor in head and neck squamous cell carcinoma.

Journal: Oncotarget
Published: October 01, 2015

Combined MET inhibition and topoisomerase I inhibition block cell growth of small cell lung cancer.

Combined MET inhibition and topoisomerase I inhibition block cell growth of small cell lung cancer.

Journal: Molecular cancer therapeutics
Published: December 12, 2013

O-6-methylguanine-deoxyribonucleic acid methyltransferase methylation enhances response to temozolomide treatment in esophageal cancer.

O-6-methylguanine-deoxyribonucleic acid methyltransferase methylation enhances response to temozolomide treatment in esophageal cancer.

Journal: Journal of carcinogenesis
Published: July 16, 2013

A web-based patient tool for preventive health: preliminary report.

A web-based patient tool for preventive health: preliminary report.

Journal: Journal of primary care & community health
Published: June 28, 2013

Utilisation of a thoracic oncology database to capture radiological and pathological images for evaluation of response to chemotherapy in patients with malignant pleural mesothelioma.

Utilisation of a thoracic oncology database to capture radiological and pathological images for evaluation of response to chemotherapy in patients with malignant pleural mesothelioma.

Journal: BMJ open
Published: October 30, 2012

Critical role for the receptor tyrosine kinase EPHB4 in esophageal cancers.

Critical role for the receptor tyrosine kinase EPHB4 in esophageal cancers.

Journal: Cancer research
Published: October 27, 2012

Role of MetMAb (OA-5D5) in c-MET active lung malignancies.

Role of MetMAb (OA-5D5) in c-MET active lung malignancies.

Journal: Expert opinion on biological therapy
Published: November 04, 2011
Showing 1-8 of 8

Last Updated: 09/26/2026